Key result
In murine models of Duchenne muscular dystrophy, the H4 hinge was essential for micro-dystrophin sarcolemmal localization and function, while the H1 hinge facilitated muscle force production.
Why the study?
Clinical-stage micro-dystrophins all carry hinge 1 (H1) and hinge 4 (H4), but whether these two hinges are essential for micro-dystrophin function in DMD models was unknown.
Are Hinge 1 and Hinge 4 essential for micro-dystrophin function in murine models of Duchenne muscular dystrophy?
Are Hinge 1 and Hinge 4 essential for micro-dystrophin function in murine models of Duchenne muscular dystrophy?
Hinge 4 is essential for micro-dystrophin function and Hinge 1 facilitates force production, informing the design of next-generation gene therapies for Duchenne muscular dystrophy.
Answers are grounded in this paper and cite their sources.
Hinge optimization merits further preclinical testing; leaves open translation to clinical micro-dystrophin gene therapy in Duchenne muscular dystrophy.
Duchenne muscular dystrophy (DMD) is a fatal muscle disease caused by dystrophin deficiency. Dystrophin consists of the amino terminus, central rod domain with 24 spectrin-like repeats and four hinges (H), cysteine-rich domain, and carboxyl terminus. Several highly abbreviated micro-dystrophins (μDys) are currently in clinical trials. They all carry H1 and H4. In this study, we investigated whether these two hinges are essential for μDy function in murine DMD models. Three otherwise identical μDys were engineered to contain H1 and/or H4 and were named H1/H4 (with both H1 and H4), ΔH1 (without H1), and ΔH4 (without H4). These constructs were packaged in adeno-associated virus serotype-9 and delivered to the tibialis anterior muscle of 3-month-old male mdx4cv mice (1E12 vector genome particles/muscle). Three months later, we detected equivalent μDys expression in total muscle lysate. However, only H1/H4 and ΔH1 showed correct sarcolemmal localization. ΔH4 mainly existed as sarcoplasmic aggregates. H1/H4 and ΔH1, but not ΔH4, fully restored the dystrophin-associated protein complex and significantly improved the specific muscle force. Eccentric contraction-induced force decline was best protected by H1/H4, followed by ΔH1, but not by ΔH4. Next, we compared H1/H4 and ΔH1 in 6-week-old male mdx mice by intravenous injection (1E13 vector genome particles/mouse). Four months postinjection, H1/H4 significantly outperformed ΔH1 in extensor digitorum longus muscle force measurements but two constructs yielded comparable electrocardiography improvements. We conclude that H4 is essential for μDys function and H1 facilitates force production. Our findings will help develop next-generation μDys gene therapy.
No takes yet. Share an insight, caveat, or question.
Wasala et al. (2022) studied Duchenne muscular dystrophy. Micro-dystrophin gene therapy (H1/H4, ΔH1, ΔH4) vs. Comparison among H1/H4, ΔH1, and ΔH4 constructs was evaluated on Sarcolemmal localization and specific muscle force. In murine models of Duchenne muscular dystrophy, the H4 hinge was essential for micro-dystrophin sarcolemmal localization and function, while the H1 hinge facilitated muscle force production.
Synapse has enriched 10 related papers. Consider them for comparative context: